R. Berges

3.6k total citations
90 papers, 2.6k citations indexed

About

R. Berges is a scholar working on Urology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R. Berges has authored 90 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Urology, 46 papers in Pulmonary and Respiratory Medicine and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R. Berges's work include Urinary Bladder and Prostate Research (49 papers), Prostate Cancer Diagnosis and Treatment (37 papers) and Hormonal and reproductive studies (29 papers). R. Berges is often cited by papers focused on Urinary Bladder and Prostate Research (49 papers), Prostate Cancer Diagnosis and Treatment (37 papers) and Hormonal and reproductive studies (29 papers). R. Berges collaborates with scholars based in Germany, United Kingdom and Netherlands. R. Berges's co-authors include Helmut Bonkhoff, John T. Isaacs, Theodor Senge, Bertrand Tombal, M. Oelke, Hugh F. English, Christopher R. Chapple, T. Senge, Hans J. Trampisch and Jürgen Windeler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Urology.

In The Last Decade

R. Berges

86 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Berges Germany	28	1.3k	1.2k	626	563	518	90	2.6k
Jack Geller United States	32	1.8k 1.4×	1.3k 1.1×	471 0.8×	694 1.2×	1.5k 2.9×	78	3.5k
Benkang Shi China	28	501 0.4×	323 0.3×	177 0.3×	851 1.5×	107 0.2×	160	2.3k
Horng‐Heng Juang Taiwan	31	350 0.3×	130 0.1×	181 0.3×	1.1k 2.0×	179 0.3×	131	2.3k
Phei‐Lang Chang Taiwan	25	566 0.5×	236 0.2×	209 0.3×	732 1.3×	73 0.1×	87	1.9k
Toru Shimazui Japan	27	465 0.4×	160 0.1×	96 0.2×	1.1k 2.0×	110 0.2×	111	2.3k
Hsin‐Chih Yeh Taiwan	23	308 0.2×	145 0.1×	57 0.1×	528 0.9×	270 0.5×	110	1.4k
Tomohiro Matsuo Japan	20	227 0.2×	180 0.2×	110 0.2×	352 0.6×	55 0.1×	130	1.2k
Bo Peng China	26	376 0.3×	69 0.1×	90 0.1×	919 1.6×	85 0.2×	119	1.9k
Cécile Acquaviva France	29	696 0.6×	36 0.0×	245 0.4×	1.5k 2.7×	125 0.2×	110	2.7k
M. J. Mitchinson United Kingdom	28	448 0.4×	25 0.0×	653 1.0×	518 0.9×	204 0.4×	72	3.2k

Countries citing papers authored by R. Berges

Since Specialization

Citations

This map shows the geographic impact of R. Berges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Berges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Berges more than expected).

Fields of papers citing papers by R. Berges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Berges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Berges. The network helps show where R. Berges may publish in the future.

Co-authorship network of co-authors of R. Berges

This figure shows the co-authorship network connecting the top 25 collaborators of R. Berges. A scholar is included among the top collaborators of R. Berges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Berges. R. Berges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sievert, Karl‐Dietrich, Martin Schönthaler, R. Berges, et al.. (2018). Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World Journal of Urology. 37(7). 1353–1360. 43 indexed citations

Höfner, K., S. Ulrich, & R. Berges. (2017). Kombinationsbehandlung des BPS mit Tamsulosin und Finasterid: Literaturübersicht und Verordnungsdaten. Urologe A. 56(5). 645–653. 1 indexed citations

Berges, R., et al.. (2017). Avanafil zur Therapie der erektilen Dysfunktion in der Praxis. MMW - Fortschritte der Medizin. 159(S5). 16–21.

Bach, Thorsten, R. Berges, K. Dreikorn, et al.. (2016). [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].. PubMed. 55(2). 195–207. 4 indexed citations

Bach, Thorsten, R. Berges, K. Dreikorn, et al.. (2016). S2e-Leitlinie der Deutschen Urologen. Instrumentelle Therapie des benignen Prostatasyndroms. 55(2). 195–207. 2 indexed citations

Höfner, K., S. Ulrich, & R. Berges. (2016). Kombinationsbehandlung des BPS mit Tamsulosin und Finasterid. Der Urologe. 56(5). 645–653. 2 indexed citations

Bach, Thorsten, R. Berges, K. Dreikorn, et al.. (2015). S2e-Leitlinie der Deutschen Urologen. Der Urologe. 55(2). 195–207. 6 indexed citations

Oelke, Matthias, R. Berges, Sandra Schläfke, & Martin Burkart. (2014). Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies. World Journal of Urology. 32(5). 1149–1154. 9 indexed citations

Berges, R., et al.. (2013). UroLift®. Der Urologe. 52(3). 350–353. 3 indexed citations

10.

Zumbé, J. & R. Berges. (2010). Zertifizierte Prostatazentren im DVPZ. Der Urologe. 49(8). 916–921. 1 indexed citations

11.

Berges, R., Andrea Gsur, K. Höfner, et al.. (2009). Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample. World Journal of Urology. 29(2). 143–148. 9 indexed citations

12.

Berges, R.. (2008). Epidemiologie des benignen Prostatasyndroms: Assoziierte Risiken und Versorgungsdaten bei deutschen Männern über 50. Urologe A. 47(2). 141–148. 2 indexed citations

13.

Farmer, Richard, Christopher R. Chapple, R. Berges, et al.. (2006). Characteristics of Patients Presenting with LUTS/BPH in Six European Countries. European Urology. 50(3). 555–562. 54 indexed citations

14.

Berges, R., et al.. (2006). Effect of a new leuprorelin formulation on testosterone levels in patients with advanced prostate cancer. Current Medical Research and Opinion. 22(4). 649–655. 28 indexed citations

15.

Tombal, Bertrand & R. Berges. (2005). How good do current LHRH agonists LHRH agonists control testosterone? - Can this be improved with Eligard (R) ?. European Urology Supplements. 4(8). 30–36. 28 indexed citations

16.

Sommerfeld, H.-J., Jens‐Christian Schewe, R. Berges, et al.. (2003). Prostatakarzinomdiagnostik durch Ultraschallelastographie. Der Urologe. 42(7). 941–945. 15 indexed citations

17.

Oelke, M., K. Höfner, R. Berges, & Udo Jonas. (2002). Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse. Der Urologe. 41(5). 425–441. 18 indexed citations

18.

Pannek, Jürgen, R. Berges, Gerald Haupt, & T. Senge. (1998). Value of the Danish prostate symptom score compared to the AUA symptom score and pressure/flow studies in the preoperative evaluation of men with symptomatic benign prostatic hyperplasia. Neurourology and Urodynamics. 17(1). 9–18. 14 indexed citations

19.

Berges, R. & John T. Isaacs. (1993). Programming events in the regulation of cell proliferation and death.. PubMed. 39(2). 356–61. 16 indexed citations

20.

Isaacs, John T., P.I. Lundmo, R. Berges, et al.. (1992). Androgen Regulation of Programmed Death of Normal and Malignant Prostatic Cells. Journal of Andrology. 13(6). 457–464. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact